Skip to main content
Clinical Trials/NCT06345248
NCT06345248Enrolling By InvitationNot Applicable

Laparoscopic-assisted Versus Ultrasonography-guided Transversus Abdominis Plane Block in Laparoscopic Sleeve Gastrectomy

Cairo University2 sites in 1 country74 target enrollmentStarted: April 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Enrolling By Invitation
Enrollment
74
Locations
2
Primary Endpoint
morphine needed

Study Overview

Brief Summary

The transversus abdominis plane (TAP) block, whereby local anesthetic is injected between the internal oblique and transversus abdominis fascia to facilitate blockade of somatic afferents nerves, is an effective, non-narcotic adjunct incorporated into many ERAS protocols. We hypothesized that surgeon delivered LAP-TAPs would be non-inferior to anesthesia-delivered US-TAPs in terms of post-operative pain control

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Elective laparoscopic sleeve gastrectomy aging > 18years BMI > 40 kg/m2, ASA score I-III

Exclusion Criteria

  • history of chronic opioid consumption suffering from contraindications to regional blocks suffering from allergy to study drugs, history of prior complex abdominal wall reconstruction

Outcomes

Primary Outcomes

morphine needed

Time Frame: UP TO 24 HOURE

mg

Secondary Outcomes

  • first analgesic request time(up to 24 hours)
  • patients' satisfaction(UP TO 24 HOURE)
  • opioid-associated side effects(UP TO 24 HOURE)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Amr Samir Wahdan

Assistant Professor

Cairo University

Study Sites (2)

Loading locations...

Similar Trials

Laparoscopic-assisted Versus... | Clinical Trial